Pharmacotherapy and cardiovascular challenges: a case report of olverembatinib-induced myocardial infarction with non-obstructive coronary arteries
Abstract The anticancer drug of tyrosine kinase-inhibitors (TKIs) has significantly improved the prognosis of patients with specific leukemia but has also increased the risk of organ adverse reactions. Herein, we present a case of a patient diagnosed with myeloproliferative neoplasms who experienced...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2024-07-01
|
| Серии: | BMC Cardiovascular Disorders |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12872-024-04011-w |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|